Literature DB >> 28159610

Brain imaging genetics in ADHD and beyond - Mapping pathways from gene to disorder at different levels of complexity.

Marieke Klein1, Marten Onnink1, Marjolein van Donkelaar1, Thomas Wolfers1, Benjamin Harich1, Yan Shi1, Janneke Dammers2, Alejandro Arias-Vásquez3, Martine Hoogman1, Barbara Franke4.   

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a common and often persistent neurodevelopmental disorder. Beyond gene-finding, neurobiological parameters, such as brain structure, connectivity, and function, have been used to link genetic variation to ADHD symptomatology. We performed a systematic review of brain imaging genetics studies involving 62 ADHD candidate genes in childhood and adult ADHD cohorts. Fifty-one eligible research articles described studies of 13 ADHD candidate genes. Almost exclusively, single genetic variants were studied, mostly focussing on dopamine-related genes. While promising results have been reported, imaging genetics studies are thus far hampered by methodological differences in study design and analysis methodology, as well as limited sample sizes. Beyond reviewing imaging genetics studies, we also discuss the need for complementary approaches at multiple levels of biological complexity and emphasize the importance of combining and integrating findings across levels for a better understanding of biological pathways from gene to disease. These may include multi-modal imaging genetics studies, bioinformatic analyses, and functional analyses of cell and animal models.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  ADHD; Animal models; Brain imaging genetics; Candidate genes; Endophenotype

Mesh:

Year:  2017        PMID: 28159610      PMCID: PMC6947924          DOI: 10.1016/j.neubiorev.2017.01.013

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  19 in total

1.  DAT1 Gene Methylation as an Epigenetic Biomarker in Attention Deficit Hyperactivity Disorder: A Commentary.

Authors:  Erika Tonelli; Esterina Pascale; Miriam Troianiello; Claudio D'Addario; Walter Adriani
Journal:  Front Genet       Date:  2020-05-11       Impact factor: 4.599

2.  Genetic associations between ADHD and dopaminergic genes (DAT1 and DRD4) VNTRs in Korean children.

Authors:  Jun Ho Hong; In Wook Hwang; Myung Ho Lim; Ho Jang Kwon; Han Jun Jin
Journal:  Genes Genomics       Date:  2018-08-11       Impact factor: 1.839

Review 3.  Heterogeneity and Subtyping in Attention-Deficit/Hyperactivity Disorder-Considerations for Emerging Research Using Person-Centered Computational Approaches.

Authors:  Sarah L Karalunas; Joel T Nigg
Journal:  Biol Psychiatry       Date:  2019-11-09       Impact factor: 13.382

4.  Genetic Markers of ADHD-Related Variations in Intracranial Volume.

Authors:  Marieke Klein; Raymond K Walters; Ditte Demontis; Jason L Stein; Derrek P Hibar; Hieab H Adams; Janita Bralten; Nina Roth Mota; Russell Schachar; Edmund Sonuga-Barke; Manuel Mattheisen; Benjamin M Neale; Paul M Thompson; Sarah E Medland; Anders D Børglum; Stephen V Faraone; Alejandro Arias-Vasquez; Barbara Franke
Journal:  Am J Psychiatry       Date:  2019-03-01       Impact factor: 18.112

Review 5.  Imaging genetics in neurodevelopmental psychopathology.

Authors:  Marieke Klein; Marjolein van Donkelaar; Ellen Verhoef; Barbara Franke
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-07       Impact factor: 3.568

Review 6.  Systematic review of mitochondrial genetic variation in attention-deficit/hyperactivity disorder.

Authors:  Stavroula V Giannoulis; Daniel Müller; James L Kennedy; Vanessa Gonçalves
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-07-07       Impact factor: 4.785

Review 7.  Treatment of adult ADHD: a clinical perspective.

Authors:  Josh Geffen; Kieran Forster
Journal:  Ther Adv Psychopharmacol       Date:  2017-10-25

8.  An expanding manifold in transmodal regions characterizes adolescent reconfiguration of structural connectome organization.

Authors:  Bo-Yong Park; Richard Ai Bethlehem; Casey Paquola; Sara Larivière; Raul Rodríguez-Cruces; Reinder Vos de Wael; Edward T Bullmore; Boris C Bernhardt
Journal:  Elife       Date:  2021-03-31       Impact factor: 8.140

9.  The lowest effective plasma concentration of atomoxetine in pediatric patients with attention deficit/hyperactivity disorder: A non-randomized prospective interventional study.

Authors:  Atsunori Sugimoto; Yutaro Suzuki; Naoki Orime; Taketsugu Hayashi; Kiyohiro Yoshinaga; Jun Egawa; Shin Ono; Takuro Sugai; Yoshimasa Inoue; Toshiyuki Someya
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

10.  Stable expression of the human dopamine transporter in N27 cells as an in vitro model for dopamine cell trafficking and metabolism.

Authors:  B S Cagle; M L Sturgeon; J B O'Brien; J C Wilkinson; R A Cornell; D L Roman; J A Doorn
Journal:  Toxicol In Vitro       Date:  2021-07-05       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.